Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

162 trials

Showing 20 of 162 results

Large-scale testing (Phase 3)Ended earlyNCT04371978
What this trial is testing

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Who this might be right for
COVID 19CoronavirusDiabetes Mellitus, Type 2+12 more
Rabin Medical Center 64
Large-scale testing (Phase 3)Study completedNCT01422876
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,405
Not applicableUnknownNCT02725502
What this trial is testing

Incretin Axis in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, Chandigarh 20
Not applicableStudy completedNCT05130463
What this trial is testing

Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,053
Early research (Phase 1)Study completedNCT02183402
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Post-approval studies (Phase 4)UnknownNCT03320031
What this trial is testing

Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

Who this might be right for
Type 2 Diabetes MellitusPeritoneal Dialysis
Yanbing Li 232
Early research (Phase 1)Study completedNCT02183610
What this trial is testing

Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 12
Large-scale testing (Phase 3)Study completedNCT02752113
What this trial is testing

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Institut für Pharmakologie und Präventive Medizin 101
Post-approval studies (Phase 4)UnknownNCT02429232
What this trial is testing

A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers

Who this might be right for
OsteoporosisDiabetes Mellitus
National Taiwan University Hospital 160
Not applicableLooking for participantsNCT06095492
What this trial is testing

Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus

Who this might be right for
Kidney Transplant; ComplicationsDiabetes Mellitus
Medanta, The Medicity, India 200
Early research (Phase 1)Study completedNCT02183428
What this trial is testing

Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02173639
What this trial is testing

Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02084056
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.

Who this might be right for
Healthy
Boehringer Ingelheim 74
Post-approval studies (Phase 4)Study completedNCT02372630
What this trial is testing

The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes
University at Buffalo 40
Early research (Phase 1)Study completedNCT03259490
What this trial is testing

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 30
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Large-scale testing (Phase 3)Study completedNCT01835678
What this trial is testing

Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.

Who this might be right for
Type 2-diabetes
University of Erlangen-Nürnberg Medical School 65
Early research (Phase 1)Study completedNCT02183389
What this trial is testing

Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 18
Large-scale testing (Phase 3)Study completedNCT01204294
What this trial is testing

Comprehensive Add on Study in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 574
Early research (Phase 1)Study completedNCT02175394
What this trial is testing

Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation